Involvement of cholecystokinin in the opioid tolerance induced by dipyrone (metamizol) microinjections into the periaqueductal gray matter of rats

Pain

Volumn 112, Issue 1-2, 2004, Pages 113-120

  Tortorici, Victor ^a,b   Nogueira, Lourdes ^a   Aponte, Yexica ^a   Vanegas, Horacio ^a  

^a INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

^b Centro de Biofisica/Bioquimica   (United States)

Author keywords

Brain stem; Descending pain control; Non opioid analgesics; Non steroidal anti inflammatory drugs; NSAIDs

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; DIPYRONE; MORPHINE; PROGLUMIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG CROSS TOLERANCE; DRUG EFFECT; DRUG TOLERANCE; HOT PLATE TEST; MALE; MICROINJECTION; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT; TAIL FLICK TEST;

ANALGESICS, OPIOID; ANIMALS; CHOLECYSTOKININ; DIPYRONE; DRUG TOLERANCE; MALE; MICROINJECTIONS; PAIN MEASUREMENT; PERIAQUEDUCTAL GRAY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 5644247900     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2004.08.006     Document Type: Article

References (46)

1. P. Boden, and G.N. Woodruff Ionic mechanisms underlying cholecystokinin action in rat brain Ann N Y Acad Sci 713 1994 129 137
2. C. Campos, R. de Gregorio, R. Garcia-Nieto, F. Gago, P. Ortiz, and S. Alemany Regulation of cyclooxygenase activity by metamizol Eur J Pharmacol 378 1999 339 347
3. K.-H. Carlsson, J. Helmreich, and I. Jurna Activation of inhibition from the periaqueductal grey matter mediates central analgesic effect of metamizol (dipyrone) Pain 27 1986 373 390
4. N.V. Chandrasekharan, H. Dai, K.L.T. Roos, N.K. Evanson, J. Tomsik, T.S. Elton, and D.L. Simmons COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression Proc Natl Acad Sci USA 99 2002 13926 13931
5. + conductance J Neurophysiol 74 1995 990 1000
6. C.T. Dourish, M.F. O'Neill, J. Coughlan, S.J. Kitchener, D. Hawley, and S.D. Iversen The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat Eur J Pharmacol 176 1990 35 44
7. P.L. Faris, B.R. Komisaruk, L.R. Watkins, and D.J. Mayer Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia Science 219 1983 310 312
8. M.M. Heinricher, S. McGaraughty, and V. Tortorici Circuitry underlying anti-opioid actions of cholecystokinin within the rostral ventromedial medulla J Neurophysiol 85 2001 280 286
9. N. Hernandez, and H. Vanegas Involvement of supraspinal and spinal endogenous opioids in the antinociceptive effect of intravenously injected dipyrone (DIP) Soc Neurosci Abstr 26 2000 661
10. N. Hernandez, and H. Vanegas Antinociception induced by PAG-microinjected dipyrone (metamizol) in rats: involvement of spinal endogenous opioids Brain Res 896 2001 175 178
11. O. Hoffmann, and Z. Wiesenfeld-Hallin The CCK-B receptor antagonist CI 988 reverses tolerance to morphine in rats NeuroReport 5 1994 2565 2568
12. T. Hökfelt, P. Morino, V. Verge, M.-N. Castel, C. Broberger, X. Zhang, M. Herrera-Marschitz, J.J. Meana, U. Ungerstedt, X.-J. Xu, J.-X. Hao, M.J.C. Puke, Z. Wiesenfeld-Hallin, A. Seiger, J. Hughes, A. Varro, and G. Dockray CCK in cerebral cortex and at the spinal level Ann N Y Acad Sci 713 1994 157 163
13. Y.F. Jacquet, and A. Lajtha The periaqueductal gray: site of morphine analgesia and tolerance as shown by 2-way cross tolerance between systemic and intracerebral injections Brain Res 103 1976 501 513
14. S.L. Jones Dipyrone into the nucleus raphe magnus inhibits the rat nociceptive tail-flick reflex Eur J Pharmacol 318 1996 37 40
15. 1A presynaptic inhibition of GABA release in rat periaqueductal gray neurons Neuropharmacology 41 2001 529 538
16. Y. Kubota, S. Inagaki, S. Shiosaka, H.J. Cho, K. Tateishi, E. Hashimura, T. Hamaoka, and M. Tohyama The distribution of cholecystokinin octapetide-like structures in the lower brain stem of the rat: an immunohistochemical analysis Neuroscience 9 1983 587 604
17. Y. Li, and J.-S. Han Cholecystokinin-octapeptide antagonizes morphine analgesia in periaqueductal gray of the rat Brain Res 480 1989 105 110
18. + conductance in hippocampal interneurons J Neurosci 17 1997 4994 5003
19. J.-L. Moreau, and H.L. Fields Evidence for GABA involvement in midbrain control of medullary neurons that modulate nociceptive transmission Brain Res 397 1986 37 46
20. G. Paxinos, and C. Watson The rat brain in stereotaxic coordinates 1998 Academic Press San Diego, CA
21. A.J. Pernia, V. Tortorici, and H. Vanegas Antinociception and tolerance elicited by acetylsalicylate in the PAG depend on endogenous opioids Abstr 10th World Congr Pain 2002 261
22. A.J. Pernia-Andrade, V. Tortorici, and H. Vanegas Induction of opioid tolerance by lysine-acetylsalicylate in rats Pain 111 2004 191 200
23. L.C. Stanfa, and A.H. Dickenson Cholecystokinin as a factor in the enhanced potency of spinal morphine following carrageenin inflammation Br J Pharmacol 108 1993 967 973
24. V. Tortorici, and H. Vanegas Putative role of medullary off- and on-cells in the antinociception produced by dipyrone (metamizol) administered systemically or microinjected into PAG Pain 57 1994 197 205
25. V. Tortorici, and H. Vanegas Antinociception induced by systemic or PAG-microinjected lysine-acetylsalicylate in rats. Effects on tail-flick related activity of medullary off- and on-cells Eur J Neurosci 7 1995 1857 1865
26. V. Tortorici, and H. Vanegas Opioid tolerance induced by metamizol (dipyrone) microinjections into the periaqueductal gray of rats Eur J Neurosci 12 2000 4074 4080
27. V. Tortorici, E. Vasquez, and H. Vanegas Naloxone partial reversal of the antinociception produced by dipyrone microinjected in the periaqueductal gray of rats. Possible involvement of medullary off- and on-cells Brain Res 725 1996 106 110
28. V. Tortorici, C.S. Robbins, and M.M. Morgan Tolerance to the antinociceptive effect of morphine microinjections into the ventral but not lateral-dorsal periaqueductal gray of the rat Behav Neurosci 113 1999 833 839
29. V. Tortorici, F. Rodriguez, L. Nogueira, Y. Aponte, and H. Vanegas Proglumide, a CCK antagonist, prevents and reverts tolerance to the antinociceptive effect of PAG-microinjected dipyrone in rats Soc Neurosci Abstr 26 2000 660
30. V. Tortorici, M.M. Morgan, and H. Vanegas Tolerance to repeated microinjection of morphine into the periaqueductal gray is associated with changes in the behavior of off- and on-cells in the rostral ventromedial medulla Pain 89 2001 237 244
31. V. Tortorici, L. Nogueira, R. Salas, and H. Vanegas Involvement of local cholecystokinin in the tolerance induced by morphine microinjections into the periaqueductal gray of rats Pain 102 2003 9 16
32. O. Valverde, R. Maldonado, M.C. Fournie-Zaluski, and B.P. Roques Cholecystokinin B antagonists strongly potentiate antinociception mediated by endogenous enkephalins J Pharmacol Exp Ther 270 1994 77 88
33. H. Vanegas, and H.-G. Schaible Prostaglandins and cyclooxygenases in the spinal cord Prog Neurobiol 64 2001 327 363
34. H. Vanegas, V. Tortorici, A. Eblen-Zajjur, and E. Vasquez PAG-microinjected dipyrone (metamizol) inhibits responses of spinal dorsal horn neurons to natural noxious stimulation in rats Brain Res 759 1997 171 174
35. E. Vasquez, and H. Vanegas The antinociceptive effect of PAG-microinjected dipyrone in rats is mediated by endogenous opioids of the rostral ventromedial medulla Brain Res 854 2000 249 252
36. C.W. Vaughan Enhancement of opioid inhibition of GABAergic synaptic transmission by cyclo-oxygenase inhibitors in rat periaqueductal grey neurones Br J Pharmacol 123 1998 1479 1481
37. C.W. Vaughan, S.L. Ingram, M.A. Connor, and M.J. Christie How opioids inhibit GABA-mediated neurotransmission Nature (London) 390 1997 611 614
38. J.S. Walker NSAID: an update on their analgesic effects Clin Exp Pharmacol Physiol 22 1995 855 860
39. J.S. Walker, and G. Levy Effect of multiple dosing on the analgesic action of diflunisal in rats Life Sci 46 1990 737 742
40. L.R. Watkins, I.B. Kinscheck, and D.J. Mayer Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide Science 224 1984 395 396
41. L.R. Watkins, I.B. Kinscheck, E.F.S. Kaufman, J. Miller, H. Frenk, and D.J. Mayer Cholecystokinin antagonists selectively potentiate analgesia induced by endogenous opiates Brain Res 327 1985 181 190
42. L.R. Watkins, I.B. Kinscheck, and D.J. Mayer Potentiation of morphine analgesia by the cholecystokinin antagonist proglumide Brain Res 327 1985 169 180
43. Z. Wiesenfeld-Hallin, P. Alster, S. Grass, O. Hoffmann, G. de Araujo Lucas, A. Plesan, and X.-J. Xu Opioid sensitivity in antinociception: role of anti-opioid systems with emphasis on cholecystokinin and NMDA receptors Prog Pain Res Manag 14 1999 237 252
44. B receptors, prevents morphine tolerance in the rat Br J Pharmacol 105 1992 591 596
45. Y. Zhou, Y.-H. Sun, Z.-W. Zhang, and J.-S. Han Accelerated expression of cholecystokinin gene in the brain of rats rendered tolerant to morphine NeuroReport 3 1992 1121 1123
46. B receptor antagonist L-365,260 in rat spinal cord Eur J Pharmacol 234 1993 147 154